These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 28193082

  • 21. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.
    Duran-Sanchon S, Vila-Navarro E, Marcuello M, Lozano JJ, Muñoz J, Cubiella J, Diez MS, Bujanda L, Lanas A, Jover R, Hernández V, Quintero E, Herreros-Villanueva M, Martín AC, Pérez-Palacios R, Arroyo R, Castells A, Gironella M.
    Biomolecules; 2019 Dec 20; 10(1):. PubMed ID: 31877644
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.
    Cancer Genomics Proteomics; 2013 Dec 20; 10(3):93-113. PubMed ID: 23741026
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L, Huang Z, Zhang H, Zhu M, Zhu W, Zhou X, Liu P.
    Cancer Biomark; 2017 Dec 20; 18(3):221-230. PubMed ID: 27983528
    [Abstract] [Full Text] [Related]

  • 24. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P, Brefort T, Backes C, Krapp M, Galata V, Beier M, Kohlhaas J, Huwer H, Meese E, Keller A.
    Oncotarget; 2016 Jan 26; 7(4):4611-23. PubMed ID: 26672767
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY, Chen CC, Chang YS, Tsai WS, You JF, Lin GP, Chen TW, Chen JS, Chan EC.
    Oncotarget; 2016 Mar 01; 7(9):10663-75. PubMed ID: 26848774
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT, Göğebakan B, Bayram S, Batmacı CY, Öztuzcu S.
    Tumour Biol; 2015 Dec 01; 36(12):9703-9. PubMed ID: 26152286
    [Abstract] [Full Text] [Related]

  • 27. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL, Law CW, Wang CW.
    BMC Cancer; 2013 Jun 08; 13():280. PubMed ID: 23758639
    [Abstract] [Full Text] [Related]

  • 28. MiR-4728-3p could act as a marker of HER2 status.
    Li H, Zhou X, Zhu J, Cheng W, Zhu W, Shu Y, Liu P.
    Cancer Biomark; 2015 Jun 08; 15(6):807-14. PubMed ID: 26406406
    [Abstract] [Full Text] [Related]

  • 29. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S, Taherikalani M, Ghanbari R, Akbari A, Shabab N, Saidijam M.
    Iran Biomed J; 2017 Mar 08; 21(2):106-13. PubMed ID: 27432735
    [Abstract] [Full Text] [Related]

  • 30. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
    Ahmed FE, Ahmed NC, Gouda MM, Vos PW, Bonnerup C.
    Methods Mol Biol; 2018 Mar 08; 1765():203-215. PubMed ID: 29589310
    [Abstract] [Full Text] [Related]

  • 31. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
    Bahnassy AA, Salem SE, El-Sayed M, Khorshid O, Abdellateif MS, Youssef AS, Mohanad M, Hussein M, Zekri AN, Ali NM.
    Exp Mol Pathol; 2018 Dec 08; 105(3):260-271. PubMed ID: 30213464
    [Abstract] [Full Text] [Related]

  • 32. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.
    Wanram S, Klaewkla N, Pinyosri P.
    Microrna; 2024 Dec 08; 13(1):56-62. PubMed ID: 38231064
    [Abstract] [Full Text] [Related]

  • 33. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S, Moreno L, Augé JM, Serra-Burriel M, Cuatrecasas M, Moreira L, Martín A, Serradesanferm A, Pozo À, Costa R, Lacy A, Pellisé M, Lozano JJ, Gironella M, Castells A.
    Gastroenterology; 2020 Mar 08; 158(4):947-957.e4. PubMed ID: 31622624
    [Abstract] [Full Text] [Related]

  • 34. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H.
    Prostate; 2013 Jun 08; 73(8):827-34. PubMed ID: 23184537
    [Abstract] [Full Text] [Related]

  • 35. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X, Wu Y, Ji M, Zhang S.
    Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115212
    [Abstract] [Full Text] [Related]

  • 36. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P, COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Ørntoft TF, Andersen CL.
    Int J Cancer; 2013 Jul 01; 133(1):67-78. PubMed ID: 23280316
    [Abstract] [Full Text] [Related]

  • 37. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
    Yamazaki N, Koga Y, Taniguchi H, Kojima M, Kanemitsu Y, Saito N, Matsumura Y.
    Oncotarget; 2017 Jan 24; 8(4):6970-6983. PubMed ID: 28036302
    [Abstract] [Full Text] [Related]

  • 38. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.
    Oncol Rep; 2013 Jul 24; 30(1):320-6. PubMed ID: 23673725
    [Abstract] [Full Text] [Related]

  • 39. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
    Choi HH, Cho YS, Choi JH, Kim HK, Kim SS, Chae HS.
    Oncology; 2019 Jul 24; 97(3):173-179. PubMed ID: 31216561
    [Abstract] [Full Text] [Related]

  • 40. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A, Galandiuk S.
    Ann Surg; 2013 Sep 24; 258(3):400-8. PubMed ID: 24022433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.